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Introduction: Premature ovarian failure and insufficiency are significant long-term side-effects of chemotherapy for
female cancer patients. Recently, stem cell transplantation has been identified as a promising treatment for
premature ovarian failure and insufficiency. We have previously demonstrated that human amniotic epithelial cells
(hAECs) migrate into injured tissue and promote the recovery of ovarian function in chemoablated mice. However,
the molecular mechanism guiding this process remains unclear.
Methods: To further investigate the effect of hAECs on chemotherapy-induced apoptosis, cultured primary hAECs
were injected intravenously into mice treated with cyclophosphamide and busulphan. Apoptosis of granulosa cells
was observed by TUNEL staining, and apoptosis-related gene expression was performed on ovarian tissue by
real-time PCR and Western blot 7 days after hAEC transplantation. Additionally, the ovarian function and fertility of
mice were assessed via counts of follicles and mating experiments at 4 weeks after hAEC transplantation.
Results: hAECs significantly inhibited tumor necrosis factor-alpha-mediated granulosa cell apoptosis induced by
chemotherapeutics and reduced the inflammatory reaction in ovaries at 7 days after transplantation. In addition,
4 weeks after transplantation, hAECs promoted the development of follicles and increased the number of cumulus
oocyte complexes in chemoablated mice. Furthermore, hAECs improved ovarian mass and increased the number of
follicles compared to those of the chemoablated group, and hAEC transplantation partially rescued the fertility of
chemoablated mice.
Conclusions: hAEC transplantation promotes ovarian function by inhibiting tumor necrosis factor-alpha-mediated
cell apoptosis and reducing inflammation in chemotherapy-induced premature ovarian failure. These results suggest
a potential molecular mechanism for the effective therapy of hAEC transplantation in chemotherapy-induced
premature ovarian failure and insufficiency.Introduction
Chemotherapy is commonly used to treat both malig-
nant neoplasms and disorders of the immune system,
and its use is accompanied by a host of side-effects. For
women in particular, the use of chemotherapy can lead
to irreversible premature ovarian failure and insuffi-
ciency (POF/POI). Additionally, POF/POI is the main
cause of female infertility [1], and the risk of POF/POI* Correspondence: laidongmei@hotmail.com
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tween the ages of 30 and 40 years [2]. Women with
POF/POI suffer from menopausal symptoms including
hot flushes, vaginal dryness and increased risk of devel-
oping osteoporosis, all of which diminish the patient's
quality of life, especially nonpregnant women [3].
Currently, there is no effective treatment for POF/POI,
and medical reversal can be challenging. Studies have
demonstrated that ovaries in the reproductive stage con-
tain a small amount of active mitotic germ cells, with
stem cell properties and the ability to differentiate into
oocytes [4]. Stem cells have indefinite proliferative cap-
acity and multi-directional differentiation potential, and
hold great promise in tissue engineering for regenerativeis distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
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quite limited at the present time, partly due to the low
quantities available for use and research.
Encouraging reports have revealed that stem cells de-
rived from a variety of human tissues including skin-
derived mesenchymal stem cells [5], adipose-derived stem
cells [6] and human amniotic fluid stem cells [7, 8] could
rescue chemotherapy-induced ovarian injury. Human am-
niotic epithelial cells (hAECs) derived from term placentas
demonstrate key advantages over other stem cell lineages,
particularly their nonimmunogenic and nontumorigenic
characteristics [9]. Furthermore, these cells can be readily
harvested in ways that avoid the ethical issues that have
arisen from other sources. Evidence has shown that cul-
tured hAECs have stem cell properties, lose telomerase ac-
tivity, and have the potential to differentiate into three
embryonic germ layers [10, 11]. Various studies have
highlighted the utility of hAECs as a novel and viable
source of stem cells for transplantation in tissue injuries,
such as reducing proliferation and activation of primary
lung fibroblasts in mice as well as reducing hyperoxia-
induced lung inflammation and structural lung damage
[12, 13]. hAECs may promote lung repair by directly
modulating macrophage recruitment and polarization
[14], reducing fetal brain injuries that may occur in re-
sponse to intrauterine inflammation [15]. Interestingly,
however, preterm hAECs exerted substantially less protect-
ive effects than full-term hAECs when administered follow-
ing acute lung injury [16]. A previous study found that
hAECs cultured in medium containing serum substitute
supplement (SSS) could differentiate into cells expressing
specific germ cell markers [17]. Previously, we demon-
strated that transplantation of term hAECs could lead them
to migrate into injured ovarian tissue, differentiate into
granulosa cells (GCs) and promote the recovery of ovarian
function [18]. Thus, hAECs may have the potential to treat
POF/POI; however, the specific cellular and molecular
mechanisms guiding this process have remained unclear.
In order to further characterize the effect of hAECs on
chemotherapy-induced ovarian injury, we established an
animal model of POF/POI by intraperitoneal injection
with cyclophosphamide combined with busulfan [18].
Cultured hAECs were transplanted into chemoablated
mice by tail vein injection, and the long-term recovery
of ovarian function was evaluated. Additionally, we eval-
uated apoptosis and inflammation induced by chemo-
therapy. We also offer a characterization and discussion
on the protective role of hAECs on the development
process of follicle and ovarian function.
Materials and methods
Isolation and culture of hAECs
Human placentas were obtained at term pregnancy dur-
ing uncomplicated Caesarean sections with written andinformed consent from woman who tested negative for
HIV-I, and hepatitis B and C. This work has been ap-
proved by the Institutional Ethics Committee of the
International Peace Maternity and Child Health Hos-
pital, and written informed consent was obtained from
all participants. Amniotic membranes were mechanically
separated from the chorion of the placenta and dissected
into several segments, following pre-cool phosphate-
buffered saline (PBS) washing. The membrane segments
were digested with 0.25 % trypsin/EDTA at 37 °C for 25
min. The resulting cell suspensions were seeded in 100
mm cell culture plates containing DMEM/F12 (Gibco,
Grand Island, NY, USA) medium supplemented with 10 %
fetal bovine serum (FBS; Gibco), streptomycin (100 U/mL;
Gibco), and penicillin (100 U/Ml; Gibco), and incubated
at 37 °C in an incubator containing 5 % CO2. Once the
density of cells reached 80–90 % confluency, cells were
collected for subsequent experiments.
POF/POI model establishment
A total of 97 female C57/BL6 wild-type mice aged from
7 to 8 weeks were obtained from Shanghai Experimental
Animal Center of Chinese Academy of Sciences. Mice
sorted into the chemoablated group (Cy; n = 44) were
given a single intraperitoneal injection of busulfan (30
mg/kg; Sigma) and cyclophosphamide (120 mg/kg,
Hengrui, Jiangsu, China) to induce premature ovarian
failure, as previously described [5]. Mice in the sham-
control group (Sham) were injected with an equal vol-
ume of PBS (n = 27). Mice in the hAEC-treated group
(Cy + hAECs; n = 26) were injected with hAECs (2 ×
106 in PBS) in the tail vein at 7 days post-induction. The
body weight for each mouse was recorded.
All procedures for animals were approved by the Insti-
tutional Animal Care and Use Committee of Shanghai,
and were performed in accordance with the National Re-
search Council Guide for Care and Use of Laboratory
Animals. Efforts were made to minimize animal suffer-
ing and limit the number of animals used in the study.
RNA extraction and real-time quantitative PCR analysis
Total RNA was isolated from cultured hAECs and ovar-
ies of mice by using Trizol (Invitrogen, Carlsbad, CA,
USA) using previously described methods [18]. Real-
time quantitative PCR reactions were performed in trip-
licate, using the SYBR Green Real-time PCR Master Mix
(Applied, Takara, Japan). PCR primers were designed ac-
cording to cDNA sequences in the NCBI database. Pri-
mer sequences used for real-time quantitative PCR are
listed in Additional file 1: Table S1. Cycling conditions
for the PCR machine were as follows: 95 °C 5 mins, 60 °C
34 s for 35 cycles. Gene expression levels were evaluated
using the delta-delta CT method, standardized to levels of
GAPDH amplification.
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Ovaries were collected from sham and chemoablated
groups at 3, 7, and 10 days after chemotherapy, and at 7
and 28 days after hAEC transplantation. Ovaries were
fixed in Bouin's solution (containing 5 % acetic acid, 9 %
formaldehyde and 0.9 % picric acid), paraffin-embedded
and serially sectioned at a thickness of 5 μm. Hematoxylin-
eosin (H&E) staining was used to evaluate the morpho-
logical structure of the ovaries, which was evaluated using
light microscopy. Follicles were categorized and counted
in every fifth section of the ovary, in a method as previ-
ously described [19, 20]. Briefly, a primordial follicle was
defined as GCs surrounding a single fusiform oocyte. A
primary follicle was surrounded by at least three granule
cells, resulting in a cubic shape, and a secondary follicle
appeared surrounded by at least two layers of GCs with
no follicular cavity. Mature follicles (Antral follicles) con-
tain at least two GCs and demonstrated evidence of fol-
licular cavity (Fig. 1B-b).TUNEL assay
In situ Cell Death Detection Kit (Roche, Germany)
was used to detect apoptosis in the ovarian tissues of
mice according to manufacturer’s instructions. The
nucleus was stained with DAPI, and the ovarian sec-
tions were evaluated using fluorescence microscopy
(Leica, Germany).Fig. 1 Chemotherapy reduced body weight of mice and the number of ovarian
chemoablated (Cy) groups. B H&E staining of ovaries in sham and treatment gro
red arrow indicated primary follicle; black arrow indicated secondary follicle; white
of follicles at different stages of development. Data represent means ± SEM; *p <
group (n = 6), Cy-3days chemoablated 3-day group (n = 6), Cy-7days chemoablatWestern blot analysis
For analysis of Western blot, protein lysate from fresh
ovarian tissue was prepared, separated on 8 % SDS-
polyacrylamide gel and transferred to a polyvinyldifluori-
dine (PVDF) membrane (Millipore). Membranes were
blocked with 10 % non-fat milk in Tris–HCl (10 mM,
pH 7.4) containing 150 mM NaCl, and 1 % Nonidet P-
40 and separately incubated with the following specific
antibodies at 4 °C overnight: rabbit polyclonal caspase-3
antibody (1:500 dilution; CST) and rabbit monoclonal
actin antibody (1:10000; Abcam, Cambridge, UK,). After
washing, membranes were incubated with horseradish
peroxidase-conjugated goat anti-rabbit IgG (1:1000;
Abcam). Visualization of blots was performed using a
standard protocol for ECL (Santa Cruz Biotechnology,
Santa Cruz, CA, USA). The relative intensity of protein
bands was quantified by digital densitometry (Image J
software, National Institutes of Health, USA). Actin
levels were used as internal standards.
Mouse superovulation
Three groups of female C57/BL6 mice were superovu-
lated at 1 month after hAEC transplantation via a single
intraperitoneal injection of pregnant mare serum go-
nadotropin (PMSG; 10 UI), followed by injection of hu-
man chorionic gonadotropin (hCG; 10 UI) 48 h later.
The cumulus oocyte complexes (COC) were collected
from the ampulla portion of the oviduct at 14–16 h afterfollicles. A Bar graph illustrating the body weight of mice in the sham and
ups, 7 and 10 days post-induction. Blue arrow indicated primordial follicle;
arrow indicated mature follicle in B-b. C Bar graph representing the number
0.05 versus Sham. Scale bar = 500 μm (a, c and d), 200 μm in b. Sham sham
ed 7-day group (n = 6), Cy-10days chemoablated 10-day group (n = 6)
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Bouin's solution for further H&E staining as described
above.
Mating protocol
Female mice underwent intraperitoneal injections with
busulfan (30 mg/kg) and cyclophosphamide (120 mg/kg),
and hAECs were transplanted into POF mice at 7 days
post-induction. Four weeks after hAEC transplantation,
two female mice in each group were enclosed with an un-
treated male for 1 month. Once mating was confirmed by
formation of the fertilization plugs, the females were sepa-
rated prior to birth of the litter. The number of pups per
pregnancy was counted.
Statistical analysis
The mean and standard error of the mean (SEM) were
calculated for experimental variables. Statistical signifi-
cance was calculated using GraphPad Prism (GraphPad
Software Inc., San Diego, CA, USA). Body weights and
ovarian weights were analyzed using the repeated mea-
sures analysis of variance (ANOVA) with the Bonferroni
post-hoc test. Western blot, quantitative PCR and fol-
licular counting data were analyzed using two-way
ANOVA testing with the least significant difference
(LSD) test. Confidence intervals of 95 % were deemed
statistically significant. Differences between groups were
considered significant when p < 0.05.
Results
Chemotherapy induces the loss of ovarian follicles
Chemotherapeutics cause a series of secondary effects to
the immune and/or reproductive systems. The sensitivity
of the ovary to chemotherapeutics is gradually increased
from puberty to adulthood [21]. In the present study, we
evaluated the body weight of mice following chemo-
therapy and observed a significant post-chemotherapy
reduction that was most pronounced at 3 and 7 days
(Fig. 1A, p < 0.05). To observe the specific changes to
ovarian structure, the ovaries of mice in the sham group
and chemoablated group were collected for pathological
analysis. The ovaries of mice in the chemoablated group
were atrophic compared to controls, containing fewer de-
veloping follicles at 7 and 10 days after chemotherapy
(Fig. 1B). Additionally, we analyzed the number of follicles
over the course of treatments. At 7 and 10 days following
chemotherapy, chemoablated mice demonstrated a statisti-
cally significant reduction in the number of primordial,
primary and secondary ovarian follicles (Fig. 1C, p < 0.05).
Chemotherapy-induced apoptosis in ovarian granulosa
cells occurs mainly in secondary follicles
To interrogate the mechanism contributing to chemo-
therapy-induced loss of follicles, we investigated theeffects of chemoablation on cell apoptosis in ovarian
tissue. TUNEL-positive cells were observed in the
ovarian section of mice at 7 days after chemotherapy,
suggesting apoptosis was largely restricted to the GC
layer of secondary follicle, in proximity to the oocytes
(Fig. 2A). To this effect, we observed significant down-
regulation of the antiapoptotic gene Bcl2 in ovaries of
chemoablated mice (Fig. 2B, p < 0.05). Studies have
demonstrated that ovaries can express tumor necrosis
factor (TNF) receptors, and is sensitive to the TNF-α-
mediated cell apoptosis pathway [22]. In order to further
investigate whether TNF-α participates in chemotherapy-
induced apoptosis, we also evaluated the expression of
TNF-α in the injured ovaries. TNF-α mRNA was signifi-
cantly increased in the ovaries of chemoablated mice as
compared to controls (Fig. 2B, p < 0.05). These results
showed that chemotherapy drugs induce GC apoptosis,
and increase inflammation within ovarian tissue.
Grafted hAECs reduce chemotherapy-induced
inflammation in ovarian tissue
To eluciate the impact of hAECs on chemotherapy-
induced inflammation, we separated hAECs from the
fresh amnion of placenta tissue in vitro. Under light mi-
croscopy, the primary hAECs appeared as cobble stone-
like epithelial cells (Fig. 3A). Real-time PCR demon-
strated that cultured hAECs expressed high mRNA
levels of Cytokeratin 19 (CK19), Vimentin, E-cadherin
(E-cad) and Octamer-binding transcription factor (Oct-4),
indicating that hAECs have the character of epithelia cells
and stem cells (Fig. 3B). Although hAEC transplantation
had no significant effect on the body weight of mice, ovar-
ian weight in the hAEC-treated group was higher than
those of the chemoablated group at 7 days (Fig. 3C and D).
Moreover, hAEC-treated mice displayed more follicles than
chemoablated mice at 7 days after hAEC transplantation
(Fig. 3E). Interleukin (IL)-1ß, a pro-inflammatory cytokine,
was significantly increased (by real-time PCR analysis) fol-
lowing chemotherapy, while the anti-inflammatory cyto-
kine (IL-10) was significantly reduced in injured ovarian
tissue. However, the increase in IL-1ß expression was
inhibited in the hAEC-treated group. These results indi-
cate that grafted hAECs may partially inhibit the
chemotherapy-induced inflammatory response to
achieve the goal of reduced of ovarian injury.
Grafted hAECs inhibit TNF-α-mediated cell apoptosis in
chemoablated mice
TNF-α is a cytokine effector that not only induces an in-
flammatory response but also regulates cell proliferation
and apoptosis through interactions with different recep-
tors [23]. In the current investigation, chemotherapy in-
creased TNF-α mRNA levels in the ovarian tissue of
chemoablated mice (Fig. 2B). We evaluated whether
Fig. 2 Chemotherapy-induced apoptosis of granulosa cells within developing follicle. A TUNEL-positive cells were observed in the ovary tissue at
7 days after chemotherapy. The red stain indicates TUNEL-positive granulosa cells. The blue DAPI stain indicates the cell nucleus. B Relative
expression of Bcl2, Bax and TNF-α mRNA in ovarian tissue at 3, 7 and 10 days after chemotherapy. Data represent means ± SEM; *p < 0.05 versus
Sham. Scale bar = 200 μm (a, b, c and d), 100 μm (e and f). Sham sham group (n = 6), Cy-3days chemoablated 3-day group (n = 6), Cy-7days
chemoablated 7-day group (n = 6), Cy-10days chemoablated 10-day group (n = 6)
Fig. 3 hAEC transplantation reduced chemotherapy-induced inflammation in ovarian tissue. A Section of dissected hAECs illustrated a cobble
stone-like epithelial cell morphology. B Relative expression of mRNA levels detected by real-time PCR in cultured hAECs. C Image of fixed ovarian
tissue in different groups at 7 days after hAEC transplantation. D Bar graph demonstrated the ovarian weights in different groups. E H&E staining
results displaying ovarian morphology in different groups at 7 days after hAEC transplantation. F Relative expression of inflammatory cytokine
mRNA levels in injured ovarian tissue analyzed by real-time PCR at 7 days after hAEC transplantation. Data represent means ± SEM; *p < 0.05
versus Sham, #p < 0.05 versus Cy. Scale bar = 200 μm in (E). Cy chemoablated group (n = 6), Cy + hAECs hAEC-treated group (n = 6), Sham sham
group (n = 4)
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genes of TNF-α-mediated apoptosis pathways such as
Fas-associated death domain (FADD), TNFR1-associated
death domain protein (TRADD) and caspase-3 in ovar-
ian tissue. Real-time PCR results showed that the mRNA
level of TNF-α, TRADD and caspase-3 was higher in
ovaries of the chemoablated group than those of the
sham group. However, following hAEC transplantation,
a significant reduction in the mRNA level of TNF-α,
TRADD and caspase-3 was observed in the chemo-
ablated ovaries (Fig. 4A, p < 0.05). Furthermore, we ob-
served a significant increase in the mRNA of the
antiapoptotic gene, Bcl2, with a concomitant decrease in
the expression of the proapoptotic gene, Bax, in ovaries
of the hAEC-treated group (Fig. 4A, p < 0.05). The pro-
tein expression of active caspase-3 in injured ovarian tis-
sue was evaluated by Western blot, revealing increased
protein expression following chemotherapy; hAEC trans-
plantation inhibited this process (Fig. 4B, p < 0.05).
Therefore, these results demonstrate that grafted hAECsFig. 4 hAEC transplantation inhibited chemotherapy-induced apoptosis in ov
Bcl2 and Bax was detected by real-time PCR in ovarian tissue at 7 days aft
densitometry analysis demonstrated that chemotherapy significantly incre
transplantation. A significant reduction of activated caspase-3 protein exp
group. Data are mean ± SEM; *p < 0.05 versus Sham; #p < 0.05 versus Cy. Cy
group (n = 6 in A, n = 4 in B), Sham sham group (n = 4 in both panels)inhibit chemotherapy-induced cell apoptosis mediated
by TNF-α within the ovaries of these mice.
Grafted hAECs increase the number of cumulus oocyte
complexes in chemoablated mice
To observe the effect of hAEC transplantation on the
process of follicle development, we carried out superovu-
lation in mice at 1 month after hAEC transplantation.
Mice were superovulated via a single intraperitoneal injec-
tion of gonadotropins. Images showed that the ovaries of
mice in the chemoablated group followed superovulation
were still atrophic following superovulation as compared
to sham and hAEC-treated groups (Fig. 5A–C). Massive
COC were acquired from the ampulla portion of the ovi-
duct in the sham group (29 ± 4.397, n = 4). Almost no
COC were observed in the chemoablated mice. However,
grafted hAECs increased COC (10 ± 1.054, n = 4) com-
pared to the chemoablated group (Fig. 5d–g, p < 0.05).
Mature follicles could be observed in ovaries of mice in
the sham and hAEC-treated groups (Fig. 5a and e,aries. A Relative mRNA expression of TNF-α, TRADD, FADD, caspase-3,
er hAECs transplantation. B Western blot results and corresponding
ased activated caspase-3 protein expression at 7 days after hAEC
ression in the hAEC-treated group compared with the chemoablated
chemoablated group (n = 6 in A, n = 4 in B), Cy + hAECs hAEC-treated
Fig. 5 hAEC transplantation increased the number of cumulus oocyte complexes (COC) in chemoablated mice. A–C Images of ovarian
morphology followed superovulation in different groups 1 month after hAEC transplantation (white arrows). D–F The morphology of COC was
observed under microscopy. G Bar graph representing the counting of COC in different groups. H–J H&E staining of ovaries followed superovulation
was used to observed follicle development. Enlargements of outlined areas are shown in panels a–f. Mature follicles are indicated by the black arrow
(a and e). Primary follicles are indicated by the black arrowhead (b, d and f). Follicular atresia is indicated by the white arrowhead (c). Data are
mean ± SEM; *p < 0.05 versus Sham; #p < 0.05 versus Cy. Scale bars = 200 μm (H–J), 100 μm (a, c and e), 50 μm (b, d and f). Cy chemoablated
group (n = 4), Cy + hAECs hAEC-treated group (n = 4), Sham sham group (n = 4)
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demonstrated follicular atresia with complete absence of
mature follicle formation (Fig. 5c). Interestingly, healthy
primary follicles could be observed in ovaries followed su-
perovulation in each of groups (Fig. 5b, d and f ). These re-
sults suggested that hAEC transplantation could rescue
the function of secondary follicles and further promote
maturation of follicles in chemoablated mice.
hAEC transplantation promotes ovarian function recovery
of chemoablated mice
To investigate the long-term effects of hAEC transplant-
ation on ovarian function, we recorded changes in body
weight at various time points following hAEC trans-
plantation. The body weight and ovarian weight of mice
in the chemoablated group were significantly lower than
those in the sham group. While hAEC transplantation
had no obvious effect on body weight (Fig. 6A), the ovar-
ian weight in the hAEC-treated group was significantly
higher than that in the chemoablated group at 28 days
following transplantation (Fig. 6B, p < 0.05). Histologic
evaluation indicated that ovaries were severely atrophic,
and the population of each stage of follicles was signifi-
cantly decreased in chemoablated mice (Fig. 6C). hAEC
transplantation greatly increased the number of healthy
follicles, especially secondary and mature follicles, andattenuated the number of follicular atresia compared to
the chemoablated group (Fig. 6C and D, p < 0.05).
To assess the impact of hAEC treatment on mouse
fertility, female mice were mated with normal males for
1 month, and the total number of pups per pregnancy
was counted. During the three mating sessions, mice in
the chemoablated group lost reproductive ability com-
pared to mice in the sham group. Conversely, the total
number of pups born in the hAEC-treated group was
greater than those in the chemoablated group (Fig. 6E,
p < 0.05). These results demonstrate that hAEC trans-
plantation can reduce chemotherapy-induced ovarian in-
jury and restore the recovery of ovary function.
Discussion
As the incidence of POF/POI continues to increase, there
is a growing need to identify novel interventions and treat-
ment strategies. In the current study, we utilized a mouse
model to mimic the clinical features of POF/POI, including
the progressive loss of follicles and the decline in fertility.
The results of this study demonstrate that hAEC trans-
plantation post-chemotherapy mitigates chemotherapy-
induced ovarian injury and restores the fertility of
chemoablated mice. These observations suggest that
hAEC transplantation may represent a future treatment
strategy for individuals suffering from POF/POI.
Fig. 6 hAEC transplantation increased the number of ovarian follicles and restored the fertility of chemoablated mice. A Bar graph illustrating
body weight of experimental and control groups following hAEC transplantation. B The ovarian weight in different groups at 28 days after hAEC
transplantation. C Histological analysis of ovaries in different groups at 28 days after hAEC transplantation. D The number of different stage
follicles counted at 28 days after hAEC transplantation. E Bar graph representing the number of pups per pregnancy at the end of mating. Data
are mean ± SEM; *p < 0.05 versus Sham; #p < 0.05 versus Cy. Scale bars in c = 500 μm (a–c), 200 μm (d–f), 100 μm (g–i), 50 μm (j–l). Cy
chemoablated group (n = 6; n = 10 in E), Cy + hAECs hAEC-treated group (n = 6; n = 10 in E), Sham sham group (n = 6; n = 5 in E)
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important to cancer therapy, can result in unintended
and severe consequences, such as female infertility.
Mechanistically, infertility results from a biological cas-
cade effect, which includes progressive loss of follicles
and extensive apoptosis of GCs [24]. GCs are an essen-
tial component of the ovarian microenvironment and
play a key role in regulating reproductive ovarian physi-
ology, including ovulation and luteal regression. Previ-
ous research has revealed that chemotherapy drugs
accelerate follicular atresia, and this process is charac-
terized by GC apoptosis [25, 26]. As supported byprevious reports, we observed a significant reduction in
the weight of mice and the number of follicles in ovar-
ian tissue following administration of chemotherapy
(Fig. 1). Prior evidence had demonstrated that docetaxel
induces moderate ovarian toxicity in mice, primarily af-
fecting GCs of early growing follicles [27]. Consistent
with these findings, we also observed the chemotherapy-
induced destruction of GCs in the developing follicle,
especially in the secondary follicle (Fig. 2). Thus, the tar-
geting of antiapoptotic activity may be a therapeutic
strategy to protect the ovary against chemotherapy-
induced injury.
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only regulates the immune response but also influences
cell differentiation, survival and apoptosis. Two disparate
signaling pathways can be induced by TNF-α depending
on the specific ligand–receptor interaction. The extrinsic
apoptosis pathway is activated when the ligand of TNF-α
binds to its death receptors (tumor necrosis factor recep-
tor 1 (TNFR1)) on the cell membrane [23, 28]. Re-
searchers have demonstrated that the ovaries of mice
express both TNF receptors and are sensitive to TNF-α-
mediated death pathway [22]. Furthermore, in post-
chemotherapy cancer patients, increased TNF-α is ob-
served in addition to enhanced TNF-related apoptosis
[29]. Moreover, intraovarian transplantation of primor-
dial follicles is unable to rescue chemotherapy-induced
ovarian injury [30]. Thus, to restore the ovarian func-
tion, it is necessary to inhibit apoptosis of GCs and
ameliorate the ovarian microenvironment of chemoab-
lated mice.
hAECs have been shown to be broadly multipotent
and nontumorigenic, thereby representing an attractive
source for stem cell therapy. Many studies indicate that
the release of cellular growth factor from transplanted
stem cells stimulates tissue regeneration, coupled with
cells that may undergo a transdifferentiation to specific
tissue cells [31, 32]. In a previous study, we demon-
strated that grafted hAECs could migrate into injured
ovarian tissue and differentiated into GCs around oo-
cytes [18]. In the current investigation, we further char-
acterized the effect of hAECs on chemotherapy-induced
apoptosis and inflammation in ovarian tissue. Our results
demonstrate that the mRNA levels of pro-inflammatory
cytokines (such as TNF-α, IL-8 and IL-1ß) are significantly
upregulated, and their elevation was observed in conjunc-
tion with the increase in follicular atresia in the ovaries of
chemoablated mice. Increased recruitment of FADD and
TRADD to the TNF-α-induced cell death signaling path-
way was shown in mice exposed to chemotherapy drugs.
Additionally, administration of chemotherapy significantly
increased active caspase-3 protein expression compared
with the sham group (Fig. 4). In contrast, hAEC trans-
plantation significantly reduced the mRNA level of FADD,
TRADD and caspase-3 in injured ovarian tissue of che-
moablated mice. Thus it can be seen that hAEC injection
could effectively alleviate the chemotherapy-induced in-
flammatory reaction in ovarian tissue. A previous study
demonstrated that human amnion epithelium stains posi-
tively for IL-4 by immunohistochemistry, and these cells
can suppress the production of TNF-α, IL-1 and IL-6 by
activated monocytes [33]. Thus, hAEC transplantation
may inhibit TNF-α-mediated apoptosis and reduced in-
flammation in chemotherapy-induced ovarian injury.
Notably, the beneficial effects of hAEC administration
may rely on genetic and environmental factors. Forinstance, hAECs failed to rescue bleomycin-induced lung
injury in a mouse strain with a defective macrophage
function [34]. However, it was demonstrated that hAECs
could improve lung repair by directly modulating
macrophage recruitment and polarization [14]. Thus,
macrophages are likely a critical component required for
effective hAEC transplantation therapy for tissue injury.
Whether hAEC transplantation in chemotherapy-treated
mice could restore ovary function through modulating
the immunologic function of recipient mice would be
worth further exploring. Additionally, transplanted
hAECs may also secret anti-inflammatory factors via a
paracrine pathway, and promoting the secretions of
growth factors may lead to a local microenvironment
more conducive for follicle growth and development.
Recently, research have reported that cultured human
amnion secreted various growth factors, such as fibroblast
growth factor-6, neurotrophin-4, vascular endothelial
growth factor receptor-3, macrophage colony-stimulating
factor receptor and heterodimer of platelet derived growth
factors AB, which may have effects within regenerating
damaged tissue [35]. While the current study describes an
interesting phenomenon and hints at a partial mechanism
for hAEC-induced ovarian regeneration after chemotherapy-
induced POF, there is still much to be understood about
the effect of cytokines secreted by hAEC on GCs and fol-
licular development of chemoablated mice using the co-
culture system.Conclusion
The present study provides important evidence that hAEC
transplantation could effectively improve ovarian function
by inhibiting cell apoptosis and reducing inflammation in
injured ovarian tissue of chemoablated mice. hAEC trans-
plantation could serve as a potential and promising new
strategy for the management of POF/POI in female cancer
survivors.Additional file
Additional file 1: Table S1. PCR primers used to detect gene
expression in ovaries of mice (m) and human amniotic epithelial cells (h).
(DOCX 17 kb)Abbreviations
ANOVA: Analysis of variance; CK19: Cytokeratin 19; COC: Cumulus oocyte
complexes; Cy: Chemoablated group; E-Cad: E-cadherin; FADD: Fas-associated
death domain; FBS: Fetal bovine serum; GC: granulosa cell; H&E: Hematoxylin-
eosin; hAEC: Human amniotic epithelial cell; hCG: human chorionic
gonadotropin; IL: Interleukin; LSD: Least significant difference; Oct-4: Octamer-
binding transcription factor 4; PBS: Phosphate-buffered saline; PMSG: Pregnant
mare serum gonadotropin; POF/POI: Premature ovarian failure and insufficiency;
PVDF: polyvinyldifluoridine; SEM: Standard error of the mean; SSS: Serum
substitute supplement; TNF: Tumor necrosis factor; TNFR1: Tumor necrosis
factor receptor 1; TRADD: TNFR1-associated death domain.
Zhang et al. Stem Cell Research & Therapy  (2015) 6:152 Page 10 of 10Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
QZ, MX and XY carried out animal model establishment,
immunohistochemistry analysis and molecular analysis. QZ and TL
participated in data acquisition, performed the statistical analysis and
manuscript editing. QW carried out the cell culture and molecular analysis.
MX, XY and QW participated in data analysis and manuscript revision. QZ
and DL designed, conceived of the study and drafted the manuscript. All
authors read and approved the final manuscript.
Acknowledgements
This work was supported by grants from Shanghai Municipal Health Bureau,
Shanghai, China (No. XBR2011069 & No. Y20140241), the NSFC (National
Natural Science Foundation of China, No. 81070533 & No. 81370678), Science
and Technology Commission of Shanghai Municipality (No.12431902201),
Shanghai Jiao Tong University Medicine-Engineering Fund (No. YG 2014QN12).
Received: 24 January 2015 Revised: 24 January 2015
Accepted: 5 August 2015
References
1. Goswami D, Conway GS. Premature ovarian failure. Hum Reprod Update.
2005;11:391–410. doi:10.1093/humupd/dmi012.
2. Sadeghi MR. New hopes for the treatment of primary ovarian insufficiency/
premature ovarian failure. J Reprod Infertil. 2013;14:1–2.
3. Panay N, Fenton A. Premature ovarian failure: a growing concern.
Climacteric. 2008;11:1–3. doi:10.1080/13697130701878635.
4. White YA, Woods DC, Takai Y, Ishihara O, Seki H, Tilly JL. Oocyte formation
by mitotically active germ cells purified from ovaries of reproductive-age
women. Nat Med. 2012;18:413–21. doi:10.1038/nm.2669.
5. Lai D, Wang F, Dong Z, Zhang Q. Skin-derived mesenchymal stem cells help
restore function to ovaries in a premature ovarian failure mouse model.
PLoS One. 2014;9:e98749. doi:10.1371/journal.pone.0098749.
6. Sun M, Wang S, Li Y, Yu L, Gu F, Wang C, et al. Adipose-derived stem cells
improved mouse ovary function after chemotherapy-induced ovary failure.
Stem Cell Res Ther. 2013;4:80. doi:10.1186/scrt231.
7. Lai D, Wang F, Chen Y, Wang L, Wang Y, Cheng W. Human amniotic fluid
stem cells have a potential to recover ovarian function in mice with
chemotherapy-induced sterility. BMC Dev Biol. 2013;13:34. doi:10.1186/
1471-213X-13-34.
8. Xiao GY, Liu IH, Cheng CC, Chang CC, Lee YH, Cheng WT, et al. Amniotic
fluid stem cells prevent follicle atresia and rescue fertility of mice with
premature ovarian failure induced by chemotherapy. PLoS One.
2014;9:e106538. doi:10.1371/journal.pone.0106538.
9. Whittle WL, Gibb W, Challis JR. The characterization of human amnion
epithelial and mesenchymal cells: the cellular expression, activity and
glucocorticoid regulation of prostaglandin output. Placenta.
2000;21:394–401. doi:10.1053/plac.1999.0482.
10. Miki T, Lehmann T, Cai H, Stolz DB, Strom SC. Stem cell characteristics of
amniotic epithelial cells. Stem Cells. 2005;23:1549–59. doi:10.1634/
stemcells.2004-0357.
11. Ilancheran S, Michalska A, Peh G, Wallace EM, Pera M, Manuelpillai U. Stem
cells derived from human fetal membranes display multilineage differentiation
potential. Biol Reprod. 2007;77:577–88. doi:10.1095/biolreprod.106.055244.
12. Vosdoganes P, Lim R, Koulaeva E, Chan ST, Acharya R, Moss TJ, et al. Human
amnion epithelial cells modulate hyperoxia-induced neonatal lung injury in
mice. Cytotherapy. 2013;15:1021–9. doi:10.1016/j.jcyt.2013.03.004.
13. Vosdoganes P, Wallace EM, Chan ST, Acharya R, Moss TJ, Lim R. Human
amnion epithelial cells repair established lung injury. Cell Transplant.
2013;22:1337–49. doi:10.3727/096368912X657657.
14. Tan JL, Chan ST, Wallace EM, Lim R. Human amnion epithelial cells mediate
lung repair by directly modulating macrophage recruitment and polarization. Cell
Transplant. 2014;23:319–28. doi:10.3727/096368912X661409.
15. Yawno T, Schuilwerve J, Moss TJ, Vosdoganes P, Westover AJ, Afandi E, et al.
Human amnion epithelial cells reduce fetal brain injury in response to
intrauterine inflammation. Dev Neurosci. 2013;35:272–82. doi:10.1159/000346683.
16. Lim R, Chan ST, Tan JL, Mockler JC, Murphy SV, Wallace EM. Preterm human
amnion epithelial cells have limited reparative potential. Placenta.
2013;34:486–92. doi:10.1016/j.placenta.2013.03.010.17. Evron A, Goldman S, Shalev E. Human amniotic epithelial cells differentiate
into cells expressing germ cell specific markers when cultured in medium
containing serum substitute supplement. Reprod Biol Endocrinol.
2012;10:108. doi:10.1186/1477-7827-10-108.
18. Wang F, Wang L, Yao X, Lai D, Guo L. Human amniotic epithelial cells can
differentiate into granulosa cells and restore folliculogenesis in a mouse
model of chemotherapy-induced premature ovarian failure. Stem Cell Res
Ther. 2013;4:124. doi:10.1186/scrt335.
19. Pedersen T, Peters H. Proposal for a classification of oocytes and follicles in
the mouse ovary. J Reprod Fertil. 1968;17:555–7.
20. Kalich-Philosoph L, Roness H, Carmely A, Fishel-Bartal M, Ligumsky H, Paglin
S, et al. Cyclophosphamide triggers follicle activation and “burnout”; AS101
prevents follicle loss and preserves fertility. Sci Transl Med. 2013;5:185ra62.
doi:10.1126/scitranslmed.3005402.
21. Aikawa NE, Sallum AM, Pereira RM, Suzuki L, Viana VS, Bonfa E, et al.
Subclinical impairment of ovarian reserve in juvenile systemic lupus
erythematosus after cyclophosphamide therapy. Clin Exp Rheumatol.
2012;30:445–9.
22. Greenfeld CR, Roby KF, Pepling ME, Babus JK, Terranova PF, Flaws JA. Tumor
necrosis factor (TNF) receptor type 2 is an important mediator of TNF alpha
function in the mouse ovary. Biol Reprod. 2007;76:224–31. doi:10.1095/
biolreprod.106.055509.
23. Geering B, Gurzeler U, Federzoni E, Kaufmann T, Simon HU. A novel
TNFR1-triggered apoptosis pathway mediated by class IA PI3Ks in
neutrophils. Blood. 2011;117:5953–62. doi:10.1182/blood-2010-11-322206.
24. Gonfloni S, Di Tella L, Caldarola S, Cannata SM, Klinger FG, Di Bartolomeo C,
et al. Inhibition of the c-Abl-TAp63 pathway protects mouse oocytes from
chemotherapy-induced death. Nat Med. 2009;15:1179–85.
doi:10.1038/nm.2033.
25. Markstrom E, Svensson E, Shao R, Svanberg B, Billig H. Survival factors
regulating ovarian apoptosis—dependence on follicle differentiation.
Reproduction. 2002;123:23–30.
26. Tan SJ, Lee LJ, Tzeng CR, Wang CW, Hsu MI, Chen CH. Targeted
anti-apoptosis activity for ovarian protection against chemotherapy-induced
ovarian gonadotoxicity. Reprod Biomed Online. 2014. doi:10.1016/
j.rbmo.2014.07.014.
27. Lopes F, Smith R, Anderson RA, Spears N. Docetaxel induces moderate
ovarian toxicity in mice, primarily affecting granulosa cells of early growing
follicles. Mol Hum Reprod. 2014;20:948–59. doi:10.1093/molehr/gau057.
28. Hutt KJ. The role of BH3-only proteins in apoptosis within the ovary.
Reproduction. 2015;149:R81–9. doi:10.1530/REP-14-0422.
29. Ganz PA, Bower JE, Kwan L, Castellon SA, Silverman DH, Geist C, et al. Does
tumor necrosis factor-alpha (TNF-alpha) play a role in post-chemotherapy
cerebral dysfunction? Brain Behav Immun. 2013;30:S99–108. doi:10.1016/
j.bbi.2012.07.015.
30. Park MR, Choi YJ, Kwon DN, Park C, Bui HT, Gurunathan S, et al. Intraovarian
transplantation of primordial follicles fails to rescue chemotherapy injured
ovaries. Sci Rep. 2013;3:1384. doi:10.1038/srep01384.
31. Diaz-Prado S, Muinos-Lopez E, Hermida-Gomez T, Rendal-Vazquez ME,
Fuentes-Boquete I, de Toro FJ, et al. Multilineage differentiation potential of
cells isolated from the human amniotic membrane. J Cell Biochem.
2010;111:846–57. doi:10.1002/jcb.22769.
32. Hou Y, Huang Q, Liu T, Guo L. Human amnion epithelial cells can be
induced to differentiate into functional insulin-producing cells. Acta Biochim
Biophys Sin. 2008;40:830–9.
33. Jones CA, Williams KA, Finlay-Jones JJ, Hart PH. Interleukin 4 production by
human amnion epithelial cells and regulation of its activity by
glycosaminoglycan binding. Biol Reprod. 1995;52:839–47.
34. Murphy SV, Shiyun SC, Tan JL, Chan S, Jenkin G, Wallace EM, et al. Human
amnion epithelial cells do not abrogate pulmonary fibrosis in mice with
impaired macrophage function. Cell Transplant. 2012;21:1477–92.
doi:10.3727/096368911X601028.
35. Grzywocz Z, Pius-Sadowska E, Klos P, Gryzik M, Wasilewska D,
Aleksandrowicz B, et al. Growth factors and their receptors derived from
human amniotic cells in vitro. Folia Histochem Cytobiol. 2014;52:163–70.
doi:10.5603/FHC.2014.0019.
